Genentech
-
Shocking! Genentech is set to close its cancer immunology research department, and star scientists are resigning
Welcome friends to leave a message in the comments section!
-
SMA领域硝烟再起，谁将杀出重围？谁将笑到最后？
2020年8月7日，美国FDA批准罗氏旗下基因泰克的Evrysdi（Risplam）用于治疗两个月及以上患有脊髓性肌萎缩症(SMA)的患者。而这次的批准，为患者带去了更为方便的给药…
